|
I
|
Tumour confined to uterus
| |
|
IA
|
≤50 % of myometrium
|
Abnormal SI in endometrial cavity or confined to inner half of myometrium
|
|
IB
|
>50 % of myometrium
|
Extends into the outer half of myometrium
|
|
II
|
Cervical stromal invasion, but not extension beyond uterus
|
Disruption or focal thinning of cervical stroma
|
|
III
|
Local or regional spread
| |
|
IIIA
|
Serosa of uterus and/or adnexa
|
Disruption or irregular uterine contour caused by tumour; ovarian nodular tumour
|
|
IIIB
|
Vagina or parametria
|
Direct tumour extension of upper vagina or/and parametrial tissues
|
|
IIIC
|
Metastases to pelvic and/or paraaortic lymph nodes
| |
|
IIIC1
|
Pelvic nodes
|
Lymph nodes >8 mm in short axis
|
|
IIIC2
|
Paraaortic nodes w/wo pelvic nodes
|
Lymph nodes >10 mm in short axis
|
|
IV
|
Bladder/bowel mucosa; or distant metastases
| |
|
IVA
|
Bladder/bowel mucosa
|
Tumour disrupts bladder or bowel muscle and invades mucosa; not bullous edema
|
|
IVB
|
Metastases abdominal and extraabdominal; inguinal lymph nodes
|
Tumour deposits at distal sites including peritoneal mets, bladder, bone liver mets, and distal lymph node metastases
|
